BMJ Best Practice

参考文献

关键文献

Rosenfeld RM, Schwartz SR, Cannon CR, et al. American Academy of Otolaryngology-Head and Neck Surgery Foundation. Clinical practice guideline: acute otitis externa. Otolaryngol Head Neck Surg. 2014;150(suppl 1):S1-S24.

Hirsch BE. Infections of the external ear. Am J Otolaryngol. 1992;13:145-155.

Roland PS, Stroman DW. Microbiology of acute otitis externa. Laryngoscope. 2002;112:1166-1177.

Osguthorpe JD, Nielsen DR. Otitis externa: review and clinical update. Am Fam Physician. 2006;74:1510-1516.

Selesnick SH. Otitis externa: management of the recalcitrant case. Am J Otology. 1994;15:408-412.

Dohar JE. Evolution of management approaches for otitis externa. Pediatr Infect Dis J. 2003;22:299-308.

Mösges R, Nematian-Samani M, Hellmich M, et al. A meta-analysis of the efficacy of quinolone containing otics in comparison to antibiotic-steroid combination drugs in the local treatment of otitis externa. Curr Med Res Opin. 2011;27:2053-2060.

Carfrae MJ, Kesser BW. Malignant otitis externa. Otolaryngol Clin North Am. 2008;41:537-549.

Sander R. Otitis externa: a practical guide to treatment and prevention. Am Fam Physician. 2001;63:927-936, 941-942.

参考文章

1.  Rosenfeld RM, Schwartz SR, Cannon CR, et al. American Academy of Otolaryngology-Head and Neck Surgery Foundation. Clinical practice guideline: acute otitis externa. Otolaryngol Head Neck Surg. 2014;150(suppl 1):S1-S24.

2.  Browning GG. Aetiopathology of inflammatory conditions of the external and middle ear. In: Kerr AG, ed. Scott Brown's otolaryngology. Oxford, UK: Butterworth-Heinemann; 1997.

3.  Hirsch BE. Infections of the external ear. Am J Otolaryngol. 1992;13:145-155.

4.  Lee SK, Lee SA, Seon SW, et al. Analysis of prognostic factors in malignant external otitis. Clin Exp Otorhinolaryngol. 2017 Sep;10(3):228-35.

5.  Walshe P, Cleary M, McConn WR, et al. Malignant otitis externa: a high index of suspicion is still needed for diagnosis. Irish Med J. 2002;95:14-16.

6.  Johnson AK, Batra PS. Central skull base osteomyelitis: an emerging clinical entity. Laryngoscope. 2014 May;124(5):1083-7.

7.  Roland PS, Stroman DW. Microbiology of acute otitis externa. Laryngoscope. 2002;112:1166-1177.

8.  Osguthorpe JD, Nielsen DR. Otitis externa: review and clinical update. Am Fam Physician. 2006;74:1510-1516.

9.  Rowlands S, Devalia H, Smith C, et al. Otitis externa in UK general practice: a survey using the UK General Practice Research Database. Br J Gen Pract. 2001;51:533-538.

10.  Selesnick SH. Otitis externa: management of the recalcitrant case. Am J Otology. 1994;15:408-412.

11.  Schwartz SR, Magit AE, Rosenfeld RM, et al. Clinical practice guideline (update): earwax (cerumen impaction). Otolaryngol Head Neck Surg. 2017 Jan;156(1_suppl):S1-29.

12.  Chan KL, Soo G, van Hasselt CA. Furunculosis. Ear Nose Throat J. 1997;76:126.

13.  Dubach P, Mantokoudis G, Caversaccio M. Ear canal cholesteatoma: meta-analysis of clinical characteristics with update on classification, staging and treatment. Curr Opin Otolaryngol Head Neck Surg. 2010 Oct;18(5):369-76.

14.  Kaushik V, Malik T, Saeed SR. Interventions for acute otitis externa. Cochrane Database Syst Rev. 2010;(1):CD004740.

15.  Kantas I, Balatsouras DG, Vafiadis M, et al. The use of trichloroacetic acid in the treatment of acute external otitis. Eur Arch Otorhinolaryngol. 2007;264:9-14.

16.  Dohar JE. Evolution of management approaches for otitis externa. Pediatr Infect Dis J. 2003;22:299-308.

17.  van Balen FA, Smit WM, Zuithoff NP, et al. Clinical efficacy of three common treatments in acute otitis externa in primary care: randomised controlled trial. BMJ. 2003;327:1201-1205.

18.  Lambert IJ. A comparison of the treatment of otitis externa with "Otosporin" and aluminium acetate: a report from a services practice in Cyprus. J R Coll Gen Pract. 1981;31:291-294.

19.  Mösges R, Schröder T, Baues CM, et al. Dexamethasone phosphate in antibiotic ear drops for the treatment of acute bacterial otitis externa. Curr Med Res Opin. 2008;24:2339-2347.

20.  Pistorius B, Westberry K, Drehobl M, et al. Prospective, randomized, comparative trial of ciprofloxacin otic drops, with or without hydrocortisone, vs. polymyxin B-neomycin-hydrocortisone otic suspension in the treatment of acute diffuse otitis externa. Infect Dis Clin Pract. 1999;8:387-395.

21.  Jones RN, Milazzo J, Seidlin M. Ofloxacin otic solution for treatment of otitis externa in children and adults. Arch Otolaryngol Head Neck Surg. 1997;123:1193-1200.

22.  Wall GM, Stroman DW, Roland PS, et al. Ciprofloxacin 0.3%/dexamethasone 0.1% sterile otic suspension for the topical treatment of ear infections: a review of the literature. Pediatr Infect Dis J. 2009;28:141-144.

23.  Mösges R, Nematian-Samani M, Hellmich M, et al. A meta-analysis of the efficacy of quinolone containing otics in comparison to antibiotic-steroid combination drugs in the local treatment of otitis externa. Curr Med Res Opin. 2011;27:2053-2060.

24.  Rahman A, Rizwan S, Waycaster C, et al. Pooled analysis of two clinical trials comparing the clinical outcomes of topical ciprofloxacin/dexamethasone otic suspension and polymyxin B/neomycin/hydrocortisone otic suspension for the treatment of acute otitis externa in adults and children. Clin Ther. 2007;29:1950-1956.

25.  Roland PS, Belcher BP, Bettis R, et al; Cipro HC Study Group. A single topical agent is clinically equivalent to the combination of topical and oral antibiotic treatment for otitis externa. Am J Otolaryngol. 2008;29:255-261.

26.  Hannley MT, Denneny JC 3rd, Holzer SS. Use of ototopical antibiotics in treating 3 common ear diseases. Otolaryngol Head Neck Surg. 2000;122:934-940.

27.  Bernstein JM, Holland NJ, Porter GC, et al. Resistance of Pseudomonas to ciprofloxacin: implications for the treatment of malignant otitis externa. J Laryngol Otol. 2007;121:118-123.

28.  Carfrae MJ, Kesser BW. Malignant otitis externa. Otolaryngol Clin North Am. 2008;41:537-549.

29.  Sreepada GS, Kwartler JA. Skull base osteomyelitis secondary to malignant otitis externa. Curr Opin Otolaryngol Head Neck Surg. 2003;11:316-323.

30.  Franco-Vidal V, Blanchet H, Bebear C, et al. Necrotizing external otitis: a report of 46 cases. Otol Neurotol. 2007;28:771-773.

31.  Phillips JS, Jones SE. Hyperbaric oxygen as an adjuvant treatment for malignant otitis externa. Cochrane Database Syst Rev. 2013;(5):CD004617.

32.  Sander R. Otitis externa: a practical guide to treatment and prevention. Am Fam Physician. 2001;63:927-936, 941-942.

33.  Martin TJ, Kerschner JE, Flanary VA. Fungal causes of otitis externa and tympanostomy tube otorrhea. Int J Pediatr Otorhinolaryngol. 2005;69:1503-1508.

34.  Mion M, Bovo R, Marchese-Ragona R, et al. Outcome predictors of treatment effectiveness for fungal malignant external otitis: a systematic review. Acta Otorhinolaryngol Ital. 2015 Oct;35(5):307-13.

35.  US Food and Drug Administration. FDA drug safety communication: FDA restricts use of prescription codeine pain and cough medicines and tramadol pain medicines in children; recommends against use in breastfeeding women. April 2017. https://www.fda.gov/ (last accessed 21 April 2017).

36.  Medicines and Healthcare Products Regulatory Agency. Codeine: restricted use as analgesic in children and adolescents after European safety review. Drug Safety Update. 2013;6:S1.

37.  European Medicines Agency. Restrictions on use of codeine for pain relief in children - CMDh endorses PRAC recommendation. June 2013. http://www.ema.europa.eu/ (last accessed 24 March 2016).

38.  Ali T, Meade K, Anari S, et al. Malignant otitis externa: case series. J Laryngol Otol. 2010;124:846-851.

使用此内容应接受我们的免责声明